BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 8633048)

  • 1. Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism.
    Missale C; Boroni F; Sigala S; Buriani A; Fabris M; Leon A; Dal Toso R; Spano P
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4240-5. PubMed ID: 8633048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
    Christian HC; Chapman LP; Morris JF
    J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve growth factor promotes the differentiation of pituitary mammotroph cells in vitro.
    Missale C; Boroni F; Frassine M; Caruso A; Spano P
    Endocrinology; 1995 Mar; 136(3):1205-13. PubMed ID: 7867574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of delta9-THC on VIP-induced prolactin secretion in anterior pituitary cultures: evidence for the presence of functional cannabinoid CB1 receptors in pituitary cells.
    Rodríguez de Fonseca F; Wenger T; Navarro M; Murphy LL
    Brain Res; 1999 Sep; 841(1-2):114-22. PubMed ID: 10546994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype.
    Missale C; Boroni F; Sigala S; Zanellato A; Dal Toso R; Balsari A; Spano P
    Endocrinology; 1994 Jul; 135(1):290-8. PubMed ID: 8013363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
    Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
    Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of prolactin gene expression by vasoactive intestinal peptide and dopamine in the turkey: role of Ca signalling.
    Al Kahtane A; Kannan M; Kang SW; El Halawani ME
    J Neuroendocrinol; 2005 Oct; 17(10):649-55. PubMed ID: 16159377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin gene expression and secretion during pregnancy and lactation in the rat: role of dopamine and vasoactive intestinal peptide.
    Escalada J; Cacicedo L; Ortego J; Melian E; Sánchez-Franco F
    Endocrinology; 1996 Feb; 137(2):631-7. PubMed ID: 8593812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense strategy unravels a dopamine receptor distinct from the D2 subtype, uncoupled with adenylyl cyclase, inhibiting prolactin release from rat pituitary cells.
    Valerio A; Alberici A; Tinti C; Spano P; Memo M
    J Neurochem; 1994 Apr; 62(4):1260-6. PubMed ID: 8133260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nerve growth factor in the anterior pituitary: regulation of secretion.
    Patterson JC; Childs GV
    Endocrinology; 1994 Oct; 135(4):1697-704. PubMed ID: 7925134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic estrogen treatment promotes a functional uncoupling of the D2 dopamine receptor in rat anterior pituitary gland.
    Munemura M; Agui T; Sibley DR
    Endocrinology; 1989 Jan; 124(1):346-55. PubMed ID: 2521206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of increased prolactin secretion by sulpiride.
    MacLeod RM; Robyn C
    J Endocrinol; 1977 Mar; 72(3):273-7. PubMed ID: 853259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of coupling between D2 dopamine receptors and calcium channels in lactotrophs from cycling female rats.
    Rendt J; Oxford GS
    Endocrinology; 1994 Aug; 135(2):501-8. PubMed ID: 8033799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D4 receptor-mediated inhibition of cyclic adenosine 3',5'-monophosphate production does not affect prolactin regulation.
    Sanyal S; Van Tol HH
    Endocrinology; 1997 May; 138(5):1871-8. PubMed ID: 9112381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
    Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
    Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve growth factor in pituitary development and pituitary tumors.
    Missale C; Spano P
    Front Neuroendocrinol; 1998 Apr; 19(2):128-50. PubMed ID: 9578983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve growth factor and its receptor in the anterior pituitary.
    Patterson JC; Childs GV
    Endocrinology; 1994 Oct; 135(4):1689-96. PubMed ID: 7925133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colocalization of NGF and TSH-like immunoreactivity in cultures of adult rat anterior pituitary cells.
    Burnham P; Conner JM; Varon S
    J Neurosci Res; 1995 May; 41(1):73-8. PubMed ID: 7674379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vesicular release of prolactin from preformed prolactin granules is stimulated by soluble factor(s) from the anterior pituitary of lactating rats.
    Huerta-Ocampo I; Fiordelisio T; Díaz N; Navarro N; Castilla A; Cárabez A; Aguilar MB; Morales T; Hernández-Cruz A; Mena F
    Neuroendocrinology; 2007; 85(1):1-15. PubMed ID: 17341846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve growth factor immunoreactivity in the anterior pituitary of the rat.
    Conner JM; Varon S
    Neuroreport; 1993 Apr; 4(4):395-8. PubMed ID: 8499596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.